Shane O LeBeau
Overview
Explore the profile of Shane O LeBeau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
1214
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Landau M, Pearce T, Carty S, Wolfe J, Yip L, McCoy K, et al.
J Am Soc Cytopathol
. 2019 Sep;
8(5):243-249.
PMID: 31543223
Introduction: At our institution, almost all thyroid fine-needle aspiration (FNA) procedures are performed by either Endocrinology or Radiology personnel. In this study, we compared the cytology and molecular adequacy rates...
2.
Ohori N, Landau M, Carty S, Yip L, LeBeau S, Manroa P, et al.
Cancer Cytopathol
. 2018 Dec;
127(3):161-168.
PMID: 30561907
Background: The benign call rate (BCR) is the percentage of cytomorphologically indeterminate cases with subsequent benign or negative molecular results. For rule-out tests, the BCR is an important parameter because...
3.
Dhir M, McCoy K, Ohori N, Adkisson C, LeBeau S, Carty S, et al.
Surgery
. 2017 Nov;
163(1):81-87.
PMID: 29128185
Background: Recent guidelines from the American Thyroid Association recommend thyroid lobectomy for intrathyroidal differentiated thyroid cancers <4 cm. Our aim was to examine histology from patients with cytologic results that...
4.
Ohori N, Wolfe J, Carty S, Yip L, LeBeau S, Berg A, et al.
Cancer Cytopathol
. 2017 Jul;
125(9):692-700.
PMID: 28678437
Background: Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) is a newly defined entity and recent studies have suggested a decrease of a few percentage points in the rate...
5.
Patel S, Carty S, McCoy K, Ohori N, LeBeau S, Seethala R, et al.
Surgery
. 2016 Nov;
161(1):168-175.
PMID: 27863786
Background: Preoperative detection of RAS mutations can contribute to cancer risk assessment in indeterminate thyroid nodules, although RAS is not always associated with malignancy. Methods: Fine-needle aspiration samples classified in...
6.
Nikiforov Y, Carty S, Chiosea S, Coyne C, Duvvuri U, Ferris R, et al.
Thyroid
. 2015 Sep;
25(11):1217-23.
PMID: 26356635
Background: Fine-needle aspiration (FNA) cytology is a common approach to evaluate thyroid nodules. It offers definitive diagnosis of a benign or malignant nodule in the majority of cases. However, 10-25%...
7.
Yip L, Nikiforova M, Yoo J, McCoy K, Stang M, Armstrong M, et al.
Ann Surg
. 2015 Aug;
262(3):519-25.
PMID: 26258321
Objectives: To correlate thyroid cancer genotype with histology and outcomes. Background: The prognostic significance of molecular signature in thyroid cancer (TC) is undefined but can potentially change surgical management. Methods:...
8.
Schoedel K, Wolfe J, Hodak S, LeBeau S, Yip L, Carty S, et al.
Cancer Cytopathol
. 2015 Aug;
123(11):678-83.
PMID: 26242638
Background: Although most unsuspected thyroid carcinomas qualify as microcarcinomas (≤1 cm), larger, nontargeted carcinomas may be found also. This study evaluated the significance of these nonmicrocarcinomas (>1 cm) in the...
9.
Nikiforov Y, Carty S, Chiosea S, Coyne C, Duvvuri U, Ferris R, et al.
Cancer
. 2014 Sep;
120(23):3627-34.
PMID: 25209362
Background: Fine-needle aspiration (FNA) cytology is a common approach to evaluating thyroid nodules, although 20% to 30% of FNAs have indeterminate cytology, which hampers the appropriate management of these patients....
10.
Radkay L, Chiosea S, Seethala R, Hodak S, LeBeau S, Yip L, et al.
Cancer Cytopathol
. 2014 Aug;
122(12):873-82.
PMID: 25132659
Background: Mutations in the RAS gene in the thyroid gland result in the activation of signaling pathways and are associated with a follicular growth pattern and the probability of a...